At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
Ankle Exoskeleton Assistancedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Optimizing Ankle Exoskeleton Assistance for Walking Across the Life Span
In Brief
A clinical study evaluating Ankle Exoskeleton Assistance for Aging. Completed, enrolled 16 participants across 1 site.
Detailed Summary
The investigators seek to determine whether ankle exoskeletons can reduce metabolic energy expenditure during walking for users across the age-spectrum.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartFeb 2020
Primary CompletionMay 2023
TodayJul 2026
First PostedJul 25, 2019
Enrollment StartFeb 4, 2020
Primary CompletionMay 23, 2023
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 6.9 years ago
Interventions
Ankle Exoskeleton Assistancedevice
The investigators will use ankle-exoskeletons to modulate the amount of mechanical power generated by the user's ankle joint. That is, participants will walk in a robotic device that either (a) adds a spring or (b) a motor in parallel with their calf muscles to help them generate a stronger propulsive push-off that could reduce the effort of walking.